University of Illinois Purchases 3D-Bioplotter for Research
An EnvisionTEC 3D-Bioplotter, a world leading bioprinter, has been purchased by the Carl R. Woese Institute for Genomic Biology (IGB) at the University of Illinois at Urbana-Champaign.
Frequently Asked Questions
What is the main topic discussed in this episode of Health Professional Radio?
This episode covers important developments in healthcare, including updates on Cancer. Health Professional Radio brings you expert insights and analysis on the latest medical news affecting healthcare professionals and patients alike.
How can healthcare professionals benefit from this information?
Healthcare professionals can stay informed about the latest developments in Cancer and related fields, enabling them to provide better patient care. Staying current with medical news helps clinicians make evidence-based decisions in their practice.
Where can I find more information about Cancer?
For more detailed information, listen to the full episode on Health Professional Radio and visit hpr.fm for additional resources. You can also subscribe to our podcast for regular updates on healthcare news and expert interviews.
It will be utilised to conduct tissue engineering and regenerative biology research.
The IGB chose the premium model of the bioprinter, which is the Manufacturer Series, that was specifically designed for advanced tissue engineering.
The university was able to purchase the 3D-Bioplotter with a grant from the National Science Foundation (NSF).
“This platform is going to enable some exciting new research efforts,” said Associate Professor Brendan Harley from the Chemical and Biomolecular Engineering Department and the Leader of the IGB’s Regenerative Biology and Tissue Engineering (RBTE) Theme.
“This bioplotter will facilitate work seeking to regenerate musculoskeletal tissues such as bone and tendon as well as to identify new ways to treat cancer,” he added.
The new 3D-Bioplotter will be placed in a campus facility where researchers can easily access it.
It is considered to be the most advanced out of all of the available 3D-Bioplotter models.
Among its unique features are a temperature-controlled platform that can boost the survival of biologic materials, an Automated Head Exchanger (AHX) with five print heads, and a multi-function HD camera that can record each individual layer of a build project for pre-clinical and clinical research.
“We’re proud to have developed a bioprinter that can be used to provide tissue engineering researchers with all of the controls and tools necessary to develop solutions for a range of healthcare and other issues,” said Jay Murray, Director of MCAD Sales, North America.
A Starter and Developer model is also offered by EnvisionTEC for those who do not need all the control and operations of the premium Manufacturer type.
The 3D-Bioplotter has already been used for research in over 250 medical, scientific and technical research papers published in peer-reviewed journals.
Medical Disclaimer
The information provided on this website is for general informational purposes only and is not intended as medical advice. Always consult with a qualified healthcare professional for medical advice, diagnosis, or treatment. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.
